ELITE LABS INC FDA Approval ANDA 040227

ANDA 040227

ELITE LABS INC

FDA Drug Application

Application #040227

Documents

Review2011-02-18

Application Sponsors

ANDA 040227ELITE LABS INC

Marketing Status

Discontinued001

Application Products

001CAPSULE;ORAL30MG0PHENTERMINE HYDROCHLORIDEPHENTERMINE HYDROCHLORIDE

FDA Submissions

ORIG1AP1997-06-18
LABELING; LabelingSUPPL2AP1999-05-07
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1999-09-02
MANUF (CMC); Manufacturing (CMC)SUPPL4AP2002-11-14
LABELING; LabelingSUPPL10AP2017-05-31STANDARD

Submissions Property Types

SUPPL3Null0
SUPPL4Null0
SUPPL10Null7

CDER Filings

ELITE LABS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 40227
            [companyName] => ELITE LABS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"PHENTERMINE HYDROCHLORIDE","activeIngredients":"PHENTERMINE HYDROCHLORIDE","strength":"30MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"PHENTERMINE HYDROCHLORIDE","submission":"PHENTERMINE HYDROCHLORIDE","actionType":"30MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.